Fes. Recell is a good product for its intended use and to ours. Purchase of Recell for us is not a priority and I think cross promotion of both products by PNV and AVH makes sense as they are complementary and not competing IMO. I don’t believe that we would get any higher market share by offering both as one product or solution. I think DW and AVH management came to the conclusion that “I scratch your back you scratch mine” Is not a bad way to promote 2 good products that complement each other at present.
Fes. Recell is a good product for its intended use and to ours....
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
0.000(0.00%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $2.34 | $2.35 | $2.27 | $1.711M | 744.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 14000 | $2.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.30 | 13896 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |